تجاوز إلى المحتوى الرئيسي

بحث

عنوان الدراسة داعم الدراسة حالة الدراسة دواء الدراسة مرحلة الدراسة رقم بروتوكول الدراسة موقع الدراسة
Superiority of Insulin Glargine Lantus vs. NPH: Treat to Normoglycemia Concept.Effect of Insulin Glargine in Comparison to Insulin NPH in Insulin-nave People With Type 2 Diabetes Mellitus Treated With at Least One OAD and Not Adequately Controlled Sanofi Ongoing Lantus® 4 Lantu_C_02762 King Abdulaziz University Hospital (Jeddah), King Fahad University Hospital (Al-Khobar)
International Diabetes Management Practice Study - IDMPS Sanofi Ongoing N/A 4 DIREG_R_05168 King Fahad Hospital (Jeddah)
Unmet needs in allergic rhinitis: International Survey on Mangment of Allergic Rhinitis by Physician and Patient. Sanofi Ongoing N/A 4 DIREG_R_06411 Soliman Fakeeh Hospital (Jeddah)
Venous Thromboembolic Risk Assessment of Post-Partum Females in Saudi Arabia Utilizing Royal College of Obstetrics and Gynecology Risk Assessment Model Sanofi Ongoing N/A 4 DIREG_L_06410 King Abdulaziz University Hospital (Jeddah)
An observational registry improving Control of Hypertension and Achieving Normalization Goal Earlier Sanofi Ongoing N/A 4 DIREG_L_05059 Erfan & Bagedo General Hospital (Jeddah)
The Influence of a rapid relief of gastro esophageal reflux disease (GERD) symptoms on the quality of life and patient satisfaction after initiating treatment with a Proton Pump Inhibitor. Sanofi Ongoing N/A 4 DRIEG_L_05705 University District Hospital (Jeddah)
International Diabetes Management Practices Study (Wave 5) Sanofi Ongoing N/A 4 DIREG_R_05941 King Fahad Hospital (Jeddah)
An observational study to monitor the efficacy and tolerability of levofloxacin 250 mg OD for treatment of simple lower UTI in Saudi Arabia Sanofi Ongoing Levofloxacin 4 LEVOF_L_05172 Erfan & Bagedo General Hospital (Jeddah)
A randomized, double-blind, placebo-controlled phase II study to investigate the efficacy and safety of riociguat (0.5 mg, 1.0 mg, 1.5 mg, 2.0 mg and 2.5 mg TID) in patients with symptomatic pulmonary hypertension associated with idiopathic interstitial pneumonias (IIP). Bayer Completed Riociguat 2 BAY 63-2521 / 13605 King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh)
Tracking Biologics Along the Silk Road Janssen-Cilag International NV Ongoing Infliximab / Golimumab / Ustekinumab 4 C0168ARA40 King Khalid University Hospital (Riyadh)
عرض 411 - 420 من 489